Biotage AB (publ)
BITGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -2.36 | 3.81 | 13.99 |
| FCF Yield | 1.86% | 2.16% | 2.32% | 1.71% |
| EV / EBITDA | 24.43 | 18.47 | 25.22 | 49.79 |
| Quality | ||||
| ROIC | 7.28% | 5.99% | 12.93% | 12.13% |
| Gross Margin | 62.69% | 61.71% | 60.54% | 61.28% |
| Cash Conversion Ratio | 1.26 | 0.94 | 0.98 | 1.31 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.50% | 14.76% | 12.77% | 3.81% |
| Free Cash Flow Growth | 26.42% | -28.78% | -8.75% | 36.24% |
| Safety | ||||
| Net Debt / EBITDA | -0.35 | -0.72 | -0.49 | -0.31 |
| Interest Coverage | 8.95 | 7.71 | 67.00 | 90.80 |
| Efficiency | ||||
| Inventory Turnover | 1.67 | 1.63 | 2.03 | 2.01 |
| Cash Conversion Cycle | 244.37 | 245.48 | 212.90 | 195.68 |